Sleep and Quality of Life in Multiple Sclerosis

Sleep and Quality of Life in Multiple Sclerosis - SLEEP-MS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00004970

Enrollment

2100

Registered

2013-05-29

Start date

2013-06-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G35.9 G47.9 F32.9 G93.3

Interventions

Group 1: Patients with early MS/clinical isolated syndrome (initial diagnosis2 years),questionnaire based survey Group 3: Patients with progressive MS (initial diagnosis>2 years), questionnaire based

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with MS according McDonald`s criteria

Exclusion criteria

Exclusion criteria: Chronic disease not associated with MS with known impact on sleep quality (neurodegenerative disease, epilepsy, rheumatological diseases, chronic musculoskeletal pain, global respiratory failure, heart failure (NYHA III-IV), alcohol or drug dependence, advanced cancer, renal failure requiring dialysis, psychotic disoders)

Design outcomes

Primary

Measure	Time frame
Prevalence of Sleep Disorders (Pittsburgh sleep quality index score), study duration: 24 months, patient related study time: 1 h	—

Secondary

Measure	Time frame
Specification of Sleep Disorders (hypersomnia, insomnia, sleep apnea, restless legs, narcolepsy, REM-sleep behaviour disorder)	—

Countries

Germany

Contacts

Public ContactSven Rupprecht

Universitätsklinikum Jena

sven.rupprecht@med.uni-jena.de03641/9396679

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026